TradingKey

• Morgan Stanley anticipates a significant M&A and IPO wave in 2026. • First-quarter earnings surpassed expectations with $3.43 diluted EPS. • Strong client engagement and wealth management fueled revenue growth.

• JPMorgan leads SpaceX IPO effort, boosting investor confidence. • Analysts maintain "Buy" ratings with increased earnings projections. • Company demonstrates strong revenue, profit, and active capital management.

• Bank of America launching cross-border real-time payments next quarter. • Analysts maintain a consensus "Buy" rating for Bank of America. • Most U.S. banks are well-capitalized, with strong Q1 2026 returns.

• IBM and Google Cloud partnered for AI solution deployment. • Analysts maintain "Buy" rating with optimistic price targets. • Alphabet raised $10 billion via equity, including Berkshire Hathaway.

Tradingkey - On June 4, Eastern Time, U.S. technology stocks experienced broad declines as Broadcom’s (AVGO) Q2 guidance was interpreted by the market as overly conservative. The three major indices diverged, with the Dow Jones Industrial Average rising over 1.7% to hit a new record high, while the tech-heavy Nasdaq Composite fell more than 0.4%. Broadcom’s share price plummeted over 15% today, reaching a low of $403.01, with its latest market capitalization reported at $1.96 trillion. The sharp sell-off in the leading custom chip company has sparked market skepticism regarding the outlook for the AI industry.

• Insider selling, valuation concerns, and market movements impacted ARM's stock. • SoftBank's stock decline and FTC investigation added to investor concerns. • ARM's strong AI demand and financial results overshadowed by negative factors.

• Bank of America upgraded UnitedHealth Group to "buy" with a higher price target. • UnitedHealth's Q1 earnings exceeded expectations due to operational efficiency. • AI investments and increased dividend signal company confidence and shareholder returns.

• Qualcomm stock declined due to semiconductor sector weakness and Broadcom's report. • Increased competition in AI PCs, notably from Nvidia, poses a threat. • Analyst concerns about valuation and flat earnings outlook persist.

• Merck beat earnings expectations and reiterated 2026 guidance. • FDA granted Breakthrough Therapy designation to a Merck lung cancer drug. • Institutional investors increased stakes; analysts raised price targets.

• Visa partners with Brale to explore stablecoin settlement on Canton Network. • Company reported strong Q2 2026 earnings, surpassing revenue and EPS expectations. • Analysts maintain positive ratings and raise price targets for Visa's stock.

• Lam Research stock fell due to U.S. China chip shipment restrictions. • Broader market decline and geopolitical tensions added pressure. • Stock may be overvalued, despite positive analyst ratings.

• Shopify increased share repurchase authorization by $3 billion. • Shopify expanded partnership with Reddit for merchant advertising. • Company stock shows technically neutral to oversold conditions.

• Retatrutide shows substantial weight loss in obesity trials. • Zepbound and Foundayo gained expanded pharmacy benefit manager coverage. • Company uses cash flow for acquisitions and pipeline diversification.

• Mastercard partners PaidBy® for open banking payments. • Mastercard expands settlement to stablecoins, fiat currencies. • Mastercard's Q1 2026 earnings surpassed analyst estimates.

• Institutional and insider selling pressured Applied Materials' share price. • Strong Q2 results and AI demand contrast with recent stock sales. • Analysts maintain positive ratings and price targets for the company.

• Nvidia's new AI chip challenges Intel's PC market dominance. • Analysts downgrade Intel shares amid competition and valuation concerns. • Intel's foundry business faces losses and manufacturing yield issues.

• Broadcom reported strong fiscal Q2 2026 results, with record revenue and profit. • Stock declined due to elevated market expectations and reiterated AI forecast. • Macquarie downgraded Broadcom rating due to Google's internal chip development.

• Micron stock fell due to peer's disappointing AI revenue guidance. • Sector-wide profit-taking impacted Micron after recent strong gains. • Memory demand remains strong, but competition and cycles pose risks.

• Broadcom's reiterated AI forecasts caused a sell-off in chip stocks. • Geopolitical tensions and rising oil prices increase market caution. • Positive AMD product news is outweighed by sector and market pressures.

TradingKey - IBM and Google Cloud have announced an expansion of their strategic AI partnership, launching a new Google Cloud Practice aimed at helping enterprises accelerate the deployment of AI applications into production environments and modernizing core systems. The core of this collaboration is not merely IBM utilizing Google Cloud technology; rather, both parties intend to integrate cloud platforms, consulting delivery, industry processes, and AI agents into a comprehensive suite of enterprise-ready implementation solutions.